+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

India Bronchitis Treatment Market 2020-2026

  • PDF Icon


  • March 2021
  • Region: India
  • Orion Market Research Private Limited
  • ID: 5332104
India Bronchitis Treatment Market Size, Share & Trends Analysis Report by Type (Drugs (Antibiotics, Anti-Inflammatory Drugs, Bronchodilators, and Others) and Oxygen Therapy) and Forecast 2020-2026.

India bronchitis treatment market is projected to witness considerable growth during the forecast period. It is due to increasing awareness of the people towards health, increasing smoking habit and rising pollution across the country. Respiratory or lung diseases are highly prevalent in the country. About 15-20 million people have asthma in the country. In terms of smoking, around 120 million people smoke in India, estimating to 10% of the world’s tobacco smokers, as per the Economics of Tobacco and Tobacco Taxation in India. Therefore, the demand for bronchitis treatment is continuously rising in the country. Moreover, the rising industrialization in India, backed by the cohesive government policies, such as ‘Make in India’ initiative will further rise the pollution level in the country. As per new survey of WHO in 2018, 14 out of 20 topmost polluted cities are in India, with Kanpur, Faridabad and Varanasi being the most polluted cities. Due to this, the people would face significant respiratory diseases in the near future and hence the need for bronchitis treatment will rise during the forecast period.

The bronchitis treatment market is classified on the basis of type of treatment, which includes drugs and oxygen therapy. The drugs segment is further segregated into antibiotics, anti-inflammatory drugs, bronchodilators, and others. Among these types of treatments, the drugs find its significant application in the bronchitis treatment across the globe. In addition, the bronchodilator is estimated to project a considerable CAGR during the forecast period. Bronchodilators are the first-line medication used to treatment of bronchitis, to clear the airway obstruction, which is considered as first-step in chronic bronchitis to ease breathing problems.

The India bronchitis treatment market is influenced by product development and advancements conducted by the market players. The key players of the bronchitis treatment market include Abbott Laboratories, Bayer AG, Cipla Ltd., GlaxoSmithKline PLC, Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. These players are playing a significant role in the growth of the bronchitis treatment market by providing various products and adopting several strategies such as merger and acquisition, partnerships and collaboration, technological development, and others.

Research Methodology

The market study of the India bronchitis treatment market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. The research analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:
  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog
The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. India Bronchitis Treatment Market Research and Analysis by Type

The Report covers:
  • Comprehensive research methodology of the India bronchitis treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the India bronchitis treatment market.
  • Insights about market determinants which are stimulating the India market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. India Bronchitis Treatment Market by Type
5.1.1. Drugs Antibiotics Anti-inflammatory drugs Bronchodilators Others (Mucolytics)
5.1.2. Oxygen Therapy

6. Company Profiles
6.1. Abbott Laboratories
6.2. Aurobindo Pharma Ltd.
6.3. Bayer AG
6.4. Boehringer Ingelheim International GmbH
6.5. Cipla Ltd.
6.6. Dr Reddy's Laboratories Ltd.
6.7. GlaxoSmithKline PLC
6.8. Lupin Pharmaceuticals, Inc.
6.9. Merck & Co., Inc.
6.10. Novartis AG
6.11. Pfizer Inc.
6.12. Sanofi SA
6.13. Teva Pharmaceutical Industries Ltd.List of Tables
1. India Bronchitis Treatment Market Research and Analysis by Type, 2019-2026 ($ Million)

List of Figures
1. India Bronchitis Treatment Market Share by Type, 2019 Vs 2026 (%)
2. India Bronchitis Treatment Market Size, 2019-2026 ($ Million)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Cipla Ltd.
  • Dr Reddy's Laboratories Ltd.
  • GlaxoSmithKline PLC
  • Lupin Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • . Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.